Survey Healthcare Global

We’re investing significantly in product and engineering to drive Apollo Intelligence’s next stage of growth—and we’re hiring a visionary SVP, Head of Product to lead the way. Working closely with Rob DeMento, this leader will shape our product strategy, build and scale a world-class team, and help transform Apollo into a truly product-led organization. Ready to build something that matters? Apply today!

Jasmina Mujanović has an exciting opportunity for Bengaluru-based candidates to join our exceptional Client Services team, working to support our EU customer base. This will be an exciting opportunity for growth and collaboration in a hybrid work environment. If you or someone you know is client-focused, detail-orientated, results-driven and looking to make a meaningful impact, we'd love to hear from you!

This month, we’re not just raising awareness of prostate cancer – we’re taking action. Prostate cancer is the second most common cancer in men, with 1.4 million new cases, globally, each year. It’s also the fifth leading cause of cancer death, with 375,000 lives lost in 2020. Risk factors include age (especially over 50), family history and ethnicity, with African American men at higher risk. Early detection is key – PSA tests and digital rectal exams (DRE) can help identify prostate cancer early and improve outcomes. At SHG, we’ve delivered 25+ research projects in this space, from patient journeys to treatment landscapes. But it’s not just about research – we’re also encouraging the men in our team to get checked, because awareness leads to action. Know the risks. Book a check-up. Start the conversation. #ProstateCancerAwareness #MensHealth #EarlyDetectionMatters

At SHG, we don’t just talk about quality – we deliver it. 🔍 Our qualitative research uncovers the real patient experience of Fabry disease, shaping strategies that put patients first. Numbers alone can’t capture the full patient experience. By combining in-home interviews, patient-tracking surveys and follow-up conversations, we explored how Fabry disease affects daily life – physically, emotionally and socially. Recruiting for rare diseases comes with challenges – but a thoughtful, patient-first approach makes all the difference. Partnering with patient associations and adapting to infusion schedules allowed us to engage meaningfully and uncover insights that are shaping future care strategies. Read the full case study and find out how SHG’s qualitative research can drive more informed decision-making: https://lnkd.in/eYbu4JVd #QualitativeResearch #PatientExperience #RareDiseaseResearch

What do HCPs think about the 2025 administration's healthcare plans? We surveyed 100 HCPs to uncover their views on the potential impact the incoming administration could have on healthcare orgs. Key insights: • 43% lack confidence in policy improvements. • Female physicians are more concerned about reproductive rights and regulatory changes. Read the full blog from Apollo Intelligence to discover more key insights into what’s shaping U.S. healthcare in 2025: https://lnkd.in/epVxraDr

Last week, Matthew Brown attended EPA Congress 2025 in Amsterdam. Over 1,500 industry leaders came together to discuss the latest developments in market access, pricing and evidence in life sciences. Two key themes stood out: 💡 AI is playing an increasingly disruptive role in real-world evidence generation, with pharmaceutical companies fully committed to leveraging data-driven decision-making to shape their strategies. 💡 The Joint Clinical Assessment (JCA) is bringing significant changes to market access, prompting companies to take proactive steps in preparing for its impact on pricing and reimbursement. It was a fascinating discussion on where the industry is heading and we’re keen to keep the conversation going! #WorldEPACongress #EPA2025 #LifeSciences

EPHMRA’s One-Day Meeting in London is underway! It’s been an exciting day so far with discussions on storytelling and the future of healthcare insights. If you're here, don’t miss the chance to chat with Tamara Burke, Dominique Bailao and Mo Rice. What a fantastic day of insights and networking in London! #EPHMRA #HealthcareResearch #MarketResearch

EPHMRA’s London One-Day Meeting is almost here! We’re looking forward to an exciting day of discussions on storytelling, market research, healthcare insights and the future of the industry. If you're attending, don’t miss the chance to chat to Tamara Burke, Dominique Bailao and Mo Rice. Join us in London tomorrow for a day full of insights and networking! #EPHMRA #HealthcareResearch #MarketResearch

Heading to World EPA Congress 2025? Say “hello” to Senior Vice President, Matthew Brown, who will be attending tomorrow! The conference is a key platform for discussions on evidence, pricing and access, covering vital topics like market access, reimbursement, rare diseases and health technology assessments. Matt is looking forward to understanding the primary intelligence needs in this space and exploring how SHG’s direct access to a community of HCP stakeholders can support life sciences companies in these crucial areas. 💡 If you're attending, feel free to connect with Matt to discuss how SHG can support your research. #WorldEPACongress #EPA2025 #LifeSciences  

How could the new administration impact U.S. healthcare? 43% of healthcare providers (HCPs) lack confidence that incoming administration policies will lead to meaningful healthcare improvements — with potential changes to Medicare/Medicaid, private insurance regulations, and access to care on the horizon. We surveyed HCPs to uncover their top concerns and priorities as they brace for the administration's potential shifts. #2025HealthcareTrends #2025Administration 👉 Download our comprehensive report to gain insight into how HCPs are preparing for the potential impact of the new administration: https://lnkd.in/dtna2-fR